- 询价
- Biointron
- B21515402
- 2025年12月06日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
We recommend that you refer to the Storage method in the COA
- 保质期：
见产品包装
- 英文名：
Recombinant Human CD22/ hFC Protein
- 库存：
充分
- 供应商：
百英生物
-
Alternative Name
Siglec-2；B-cell receptor CD22; BL-CAM; B-lymphocyte cell adhesion molecule; CD22 antigenMGC130020; CD22 molecule; CD22; sialic acid binding Ig-like lectin 2; Sialic acid-binding Ig-like lectin 2; Siglec2; Siglec-2; SIGLEC2FLJ22814; T-cell surface antigen Leu-14
-
Target
CD22
-
Source
Human CD22 was expressed from HEK293 with human IgG1 FC at the C-terminal
-
Sequence
Asp20-Arg687
-
Protein structure:
P20273hFC
-
Molecular Characterization:
The protein has a calculated MW of 101kDa.The reducing (R) heterodimer protein migrates as 130-150 kDa due to glycosylation
-
Purity:
SDS-PAGE>95%
-
Reconstitution:
sterile H2O
-
Endotoxin:
<1EU/mg
-
Formulation:
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Determined by SDS-PAGE, the purity of the protein is greater than 95%.
When Recombinant Human CD22/ hFC Protein is immobilized at 2µg/mL (100 µL/well), the concentration of Anti-Human CD22(pinatuzumab) that produces 50% of the optimal binding response is approximately 60 ng/ml.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
